-
Lifeward (LFWD) files for $100M share and warrant offering
-
Lifeward expands ReWalk exoskeleton distribution to Mexico, Thailand, UAE
-
Lifeward (LFWD) PT Lowered to $4.50 at H.C. Wainwright
-
ReWalk Robotics Ltd. (LFWD) Tops Q3 EPS by 2c
-
DHA announces contract award to Lifeward (LFWD)
-
Lifeward promotes Almog Adar to CFO from VP of finance role
-
Lifeward expands AlterG distribution to UAE and Gulf region
-
Lifeward (LFWD) Prices 4M Share Offering at $0.65/sh
-
Lifeward (LFWD) Files for 4M Share and Warrant Offering
-
Lifeward (LFWD) Names Mark Grant as New CEO
-
ReWalk Robotics Ltd. (LFWD) Misses Q1 EPS by 18c
-
Lifeward (LFWD) Files $100M Mixed Shelf
-
Lifeward (LFWD) launches ReWalk7 Personal Exoskeleton in the U.S.
-
Lifeward (LFWD): FDA Issues Clearance for ReWalk 7 Exoskeleton
-
H.C. Wainwright Reiterates Buy Rating on Lifeward (LFWD)
-
ReWalk Robotics Ltd. (LFWD) Misses Q4 EPS by 19c
-
Lifeward (LFWD) and MYOLYN Expand Partnership to Enhance Patient Access to MyoCycle FES Cycling Therapy System for Home Use
-
Lifeward (LFWD) Announces CEO Change
-
Laidlaw Starts Lifeward (LFWD) at Buy
-
Lifeward (LFWD) Finalizes Personal Exoskeleton Reimbursement Agreement with BARMER
-
Lifeward (LFWD) Prices 1.82M Share Offering at $2.75/sh
-
Lifeward (LFWD): Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons
-
Lifeward (LFWD) Appoints Robert J. Marshall to Its Board
-
Lifeward (LFWD) Streamlines U.S. Operations
-
Lifeward (LFWD) Launches Direct Sales of AlterG Product Line in Germany
-
Lifeward (LFWD) PT Raised to $13 at H.C. Wainwright
-
ReWalk Robotics Ltd. (LFWD) Tops Q2 EPS by 13c, provides guidance
-
Lifeward (LFWD) Appoints Joseph E. Turk as Incoming Chairman

